Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
15.58
+0.09 (0.60%)
At close: Dec 30, 2025
Extendicare Market Cap
Extendicare has a market cap or net worth of $1.47 billion as of December 30, 2025. Its market cap has increased by 134.04% in one year.
Market Cap
1.47B
Enterprise Value
1.59B
Revenue
1.14B
Ranking
n/a
PE Ratio
22.46
Stock Price
$15.58
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has increased from 973.52M to 1.47B, an increase of 50.71%. That is a compound annual growth rate of 1.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 1.47B | 137.93% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |